GEODE CAPITAL MANAGEMENT, LLC - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 22 filers reported holding CATALYST BIOSCIENCES INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$124,818
+31.5%
258,746
-4.2%
0.00%
Q2 2023$94,943
+69.9%
270,0330.0%0.00%
Q1 2023$55,896
+38716.7%
270,033
-1.7%
0.00%
Q4 2022$144
-99.9%
274,587
-0.2%
0.00%
Q3 2022$138,000
-71.8%
275,2650.0%0.00%
Q2 2022$489,000
+148.2%
275,265
-8.0%
0.00%
Q1 2022$197,000
-24.5%
299,201
+4.4%
0.00%
Q4 2021$261,000
-81.9%
286,585
-18.5%
0.00%
Q3 2021$1,444,000
+0.3%
351,541
+5.7%
0.00%
Q2 2021$1,439,000
-46.6%
332,479
-37.8%
0.00%
Q1 2021$2,693,000
+34.5%
534,372
+68.4%
0.00%
Q4 2020$2,002,000
+62.9%
317,326
+10.9%
0.00%
Q3 2020$1,229,000
-13.6%
286,017
+18.0%
0.00%
Q2 2020$1,422,000
+174.5%
242,405
+104.3%
0.00%
Q1 2020$518,000
-64.3%
118,668
-44.3%
0.00%
Q4 2019$1,450,000
+177.2%
213,184
+100.0%
0.00%
Q3 2019$523,000
-23.5%
106,592
+14.7%
0.00%
Q2 2019$684,000
-38.8%
92,892
-32.6%
0.00%
Q1 2019$1,118,000
-50.8%
137,874
-52.2%
0.00%
Q4 2018$2,274,000
+52.1%
288,350
+107.8%
0.00%
Q3 2018$1,495,000
-23.3%
138,770
-16.9%
0.00%
-100.0%
Q2 2018$1,948,000
+20.3%
166,932
+165.9%
0.00%0.0%
Q1 2018$1,619,000
+327.2%
62,775
+125.8%
0.00%
Q4 2017$379,000
+564.9%
27,803
+123.6%
0.00%
Q2 2017$57,00012,4320.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q2 2017
NameSharesValueWeighting ↓
Sio Capital Management, LLC 471,448$5,502,0003.04%
ACUTA CAPITAL PARTNERS, LLC 830,000$9,686,0001.72%
NEXTHERA CAPITAL LP 786,865$9,183,0001.42%
Ghost Tree Capital, LLC 355,000$4,143,0001.22%
Point72 Europe (London) LLP 83,500$974,0000.52%
Virtus ETF Advisers LLC 31,061$362,0000.32%
Eventide Asset Management 246,000$2,871,0000.12%
Kalos Management, Inc. 8,500$244,0000.11%
MARSHALL WACE, LLP 550,352$6,423,0000.10%
GSA CAPITAL PARTNERS LLP 157,145$1,834,0000.09%
View complete list of CATALYST BIOSCIENCES INC shareholders